Darwin, C. The Expression of the Emotions of Man and Animals. London: John Murray; 1872.
Wilson, SAK. Some problems in neurology. II: Pathological laughing and crying. J Neurol Psychophathol. 1924; 4: 299–333.
Cummings, J, Gilbart, J, Andersen, G. Pseudobulbar affect—a disabling but under-recognised consequence of neurological disease and brain injury. Eur Neurol Rev. 2013; 8(2): 74–81.
Miller, A, Pratt, H, Schiffer, RB. Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother. 2011; 11(7): 1077–1088.
Arciniegas, DB, Topkoff, J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry. 2000; 5(4): 290–306.
Schiffer, R, Pope, LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci. 2005; 17(4): 447–454.
Wortzel, HS, Oster, TJ, Anderson, CA, Arciniegas, DB. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs. 2008; 22(7): 531–545.
Cummings, JL, Arciniegas, DB, Brooks, BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006; 11(6): 1–7.
Cummings, JL. Involuntary emotional expression disorder: definition, diagnosis, and measurement scales. CNS Spectr. 2007; 12(4 Suppl 5): 11–16.
Parvizi, J, Coburn, KL, Shillcutt, SD, Coffey, CE, Lauterbach, EC, Mendez, MF. Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2009; 21(1): 75–87.
Parvizi, J, Anderson, SW, Martin, CO, Damasio, H, Damasio, AR. Pathological laughter and crying: a link to the cerebellum. Brain. 2001; 124(Pt 9): 1708–1719.
Insel, T, Cuthbert, B, Garvey, M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010; 167(7): 748–751.
Stahl, SM. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental Illnesses. CNS Spectr. 2013; 18(2): 65–68.
Stahl, SM. Stahl’s Essential Psychopharmacology. 4th ed. Cambridge, UK: Cambridge University Press; 2013.
Stahl, SM, Grady, M. Stahl’s Illustrated: Drug Abuse and Disorders of Impulsivity. New York: Cambridge University Press; 2012.
Stahl, SM. Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits. CNS Spectr. 2014; 19(5): 357–365.
Stahl, SM. Is impulsive violence an addiction? The habit hypothesis. CNS Spectr. 2015; 20(3): 165–169.
Grant, JE, Kim, SW. Brain circuitry of compulsivity and impulsivity. CNS Spectr. 2014; 19(1): 21–27.
Fineberg, NA, Chamberlain, SR, Goudriaan, AE, et al. New developments in human neurocognition: clinical, genetic and brain imaging correlates of impulsivity and compulsivity. CNS Spectr. 2014; 19(1): 69–89.
Berlin, GS, Hollander, E. Compulsivity, impulsivity, and the DSM 5 process. CNS Spectr. 2014; 19(1): 62–68.
Everitt, BJ, Robbins, TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005; 8(11): 1481–1489.
Everitt, BJ, Robbins, TW. From ventral to dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev. 2013; 37(9 Pt A): 1946–1954.
American Psychiatric Association. Diagnostic and Statistical Manual of the American Psychiatric Association. 5th ed. Washington, DC: American Psychiatric Press; 2013.
Stahl, SM. Mechanism of action of dextromethorphan/quinidine: comparison with ketamine. CNS Spectr. 2013; 18(5): 225–227.
Cummings, J, Lyketsos, C, Tariot, P, et al. Dextromethorphan/quinidine (AVP-923) efficacy and safety for treatment of agitation in Alzheimer’s disease: results from a Phase 3 Study (NCT01584440). Poster#NR11. Presented at: American Association for Geriatric Psychiatry Annual Meeting; March 27–30, 2015; New Orleans, LA.
Garcia-Baran, D, Johnson, TM, Wagner, J, Shen, J, Geers, M. Therapeutic approach of a high functioning individual with traumatic brain injury and subsequent emotional volatility with feathers of pathological laughter and crying with dextromethorphan/quinidine. Medicine (Baltimore). 2016; 95(12): e2886.
Messias, E, Everett, B. Dextromethorphan and quinidine combination in emotional lability associated with depression: a case report. Prim Care Companion CNS Disord. 2012; 14(5): PCC.12l01400.
Kelly, TF, Lieberman, DZ. The utility of the combination of dextromethorphan and quinidine in the treatment of bipolar II and bipolar NOS. J Affect Disord. 2014; 167: 333–335.